Anti Osteoporosis Therapy And Fracture Healing Market

Anti-Osteoporosis Therapy and Fracture Healing Market: Europe to Closely Trail North America with Leading Growth Rate: Global Industry Analysis (2012 - 2017) & Opportunity Assessment (2018 - 2026)

Proactive measures such as healthcare cost containment, primary care delivery, innovation in medical procedures (3-D printing, block chain, and robotic surgery to name a few), safe and effective drug delivery, and well-defined healthcare regulatory compliance models are targeted at placing the sector on a high growth trajectory across key regional markets. Among the various drug types in the global anti-osteoporosis therapy and fracture healing market, the largest share was occupied by Bisphosphonates with 38.4% in 2017, and this is expected to reach around US$ 5,941 Mn by the end of 2026.

North America to Lead the Global Market in the Long Run

By the end of 2026, North America is expected to dominate the market and reach a valuation of around US$ 4,895 Mn. This growth can be attributed to expanding interest in R&D for the disclosure of new and inventive medications, rising rate of the geriatric populace, and expanding commonness of way of life related illnesses in the region. The Asia Pacific anti-osteoporosis therapy and fracture healing market is expected to display high development rates in the conjectured time frame. India and China are relied upon to be the quickest developing markets for anti-osteoporosis therapy and fracture healing in the Asia Pacific region. A portion of the key variables driving the worldwide anti-osteoporosis therapy and fracture healing market in developing nations includes rising awareness about osteoporosis, a vast pool of patients, rising occurrence of geriatric populace, changing ways of life and expanding social insurance use.

Worldwide anti-osteoporosis therapy and fracture healing market is expected to grow incessantly over the years ahead attributing to quick development of the healthcare industry and healthcare expenditure in developing economies such as China and India, and expanding advantages of anti-osteoporosis therapies over different osteoporosis treatments.

anti-osteoporosis-therapy-and-fracture-healing-market.jpg

Bisphosphonates to be Key Drug Type in North America

The global anti-osteoporosis therapy and fracture healing market has been segmented on the basis of drug type into bisphosphonates, calcitonin, estrogen or hormone replacement therapy, biologics, and anabolics. Biophosphonates is expected to emerge as the most preferred drug type in North America owing to its benefits and price point. Moreover, bisphosphonates, estrogen therapy, and selective estrogen receptor modulators (SERMs) are considered core classes in the global osteoporosis drugs market. Nevertheless, as the drugs belonging to these classes were invented decades ago, patents of most of the molecules and formulations have already expired or scheduled to expire by 2020.

Companies such as Forteo have increased the lumbar spine bone mineral density by 0.059 grams per square centimeters in comparison to alendronate, which increased it by 0.028 grams per square centimeters. Furthermore, bisphosphonates and estrogen therapy are identified as drug classes with chronic side effects such as jaw death, vaginal bleeding and uterus cancer. These chronic side effects have risen the need for the development of new drugs with less or virtually no side effects. SERM drugs (Evista, Duavee) were launched to overcome the side effects of estrogens. Chronic side effects of established drugs is another factor that is expected to trigger the demand for new drug development and is anticipated to support the growth of the osteoporosis drugs market in the region over the course of the forecast period.

A new market research report has been published in the repository of Future Market Insights (FMI) on the anti-osteoporosis therapy and fracture healing market. The report provides incisive insights on the chronological growth trajectory of the market along with the present and future growth prospects present in the market. The report offers an exclusive analysis of the global market along with regional and segment based insights.

Anti-Osteoporosis Therapy and Fracture Healing Market: Overview 

The report presents the summation of the market including an official abstract that draws out the centre examples progressing in the market. It furthermore discusses on a couple of facets, for example, drivers, obstacles, and prospects that have been found in the global market. It also acquaints readers with figures related to volume, value, and development rate of the market from a growth point of view. With respect to market segmentation, each segment is analysed in detail and presented in the report. The report also presents an evaluation in the light of the market circumstance and presents a value chain analysis of the products and applications in question. A year to year progression of the market has likewise been offered in the report for the reader to be particularly aware of the changing scenario of the global market.

Anti-Osteoporosis Therapy and Fracture Healing Market: Taxonomy

Region

Drug Type

Route of Administration

Distribution Channel

  • North America

  • Bisphosphonates

  • Oral

  • Hospital Pharmacies

  • Latin America

  • Calcitonin

  • Injectable

  • Private Clinics

  • Europe

  • Estrogen or Hormone Replacement Therapy

 

  • Drug Stores

  • Japan

  • Biologics

 

  • Retail Pharmacies

  • APEJ

  • Anabolics

 

  • E-Commerce

  • MEA

 

 

 

Anti-Osteoporosis Therapy and Fracture Healing Market: Research Methodology

The report is the end result of the cautious research work of the market analysts employing reliable sources. The information introduced has been studied carefully by industry experts of FMI. The data that has been presented here has been assembled from various tried and tested sources. The figures have also been checked by the examiners and can be used to settle on key decisions and to formulate strategies.

Anti-Osteoporosis Therapy and Fracture Healing Market: Competitive Landscape

The market study conveys an immense outlook on the engaged scene of the overall anti-osteoporosis therapy and fracture healing market. It features the competition prevalent among the present vendors in the market and also lays emphasis on the future circumstance of the market. The profile of the players is based on a SWOT examination sought down by company angle, product portfolio, strategies, finance related information, and year-to-year projections. The organisations have been explored minutely covering their key developments, innovations as well as mergers and acquisitions and agreements with other prominent organisations. The report also includes a PEST analysis for making it a convenient read for readers.

Reasons Why Our Report is Trustworthy

The reports made by our industry analysts are credible and have been researched and validated from several primary and secondary resources. What makes us unique is the fact that along with presenting an analysis of the market’s historical and present scenario, we also present a forecast review of the market for the benefit of our readers. The presentation is unique in the form of various charts, tables, and diagrams. Every bit of information present in the market research report is unique. Expert opinions are also present in the report that can be directly used by the readers to make future decisions.